A yeast display system for engineering functional peptide-MHC complexes

Susan E. Brophy, Phillip D. Holler, David M Kranz

Research output: Contribution to journalArticle

Abstract

In a cellular immune response, antigenic peptides derived by intracellular processing of foreign pathogens are bound to the class I major histocompatability complex (MHC I) and presented to CD8+ cytotoxic T cells. Although the crystal structures of several different MHC products have been solved, many MHC molecules, including some associated with diseases, have not been amenable to biochemical and structural studies. The variability in this success is based largely on the fact that peptide-MHC complexes vary extensively in their stability. These properties also are intimately tied to the biological activity of the complexes. The ability to apply the techniques of directed evolution to this system in order to engineer stable complexes has been complicated by the trimeric structure of peptide-MHC complexes, requiring association of three polypeptides: the heavy chain, β2-microglubulin (β2m), and a short peptide. We show here that single-chain forms of peptide-MHC complexes can be expressed as Aga-2 fusions on the surface of yeast. Three different complexes, SIYRYYGL-Kb-β2m (SIYR-Kb), EQYKFYSV-Kb-β2m (dEV8-Kb), and SIINFEKL-Kb-β2m (OVA-Kb), were expressed on yeast and detected by flow cytometry with a conformation-specific anti-Kb antibody (B.8.24.3). In addition, yeast displaying Kb loaded with exogenous SIYR and OVA peptides were recognized by a high-affinity T cell receptor that is specific for SIYR-Kb and by an antibody (25.D1-16) that is specific for OVA-Kb, respectively. Finally, yeast that display the SIYRYYGL-Kb also directly stimulated CD69 up-regulation on naive 2C T cells. Hence, yeast display represents a technology that can be used for directed evolution of any of the components of the trimeric pep-MHC complex.

Original languageEnglish (US)
Pages (from-to)235-246
Number of pages12
JournalJournal of Immunological Methods
Volume272
Issue number1-2
DOIs
StatePublished - Jan 15 2003

Fingerprint

Yeasts
Peptides
T-Lymphocytes
T-Cell Antigen Receptor
Cellular Immunity
Anti-Idiotypic Antibodies
Flow Cytometry
Up-Regulation
Technology
Antibodies
superagonist SIYR

Keywords

  • Agonist peptides
  • Antigen presentation
  • Peptide-MHC
  • T cell activation
  • Yeast display

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

A yeast display system for engineering functional peptide-MHC complexes. / Brophy, Susan E.; Holler, Phillip D.; Kranz, David M.

In: Journal of Immunological Methods, Vol. 272, No. 1-2, 15.01.2003, p. 235-246.

Research output: Contribution to journalArticle

Brophy, Susan E. ; Holler, Phillip D. ; Kranz, David M. / A yeast display system for engineering functional peptide-MHC complexes. In: Journal of Immunological Methods. 2003 ; Vol. 272, No. 1-2. pp. 235-246.
@article{2b961d7e2727487e8a06f38d457a71b9,
title = "A yeast display system for engineering functional peptide-MHC complexes",
abstract = "In a cellular immune response, antigenic peptides derived by intracellular processing of foreign pathogens are bound to the class I major histocompatability complex (MHC I) and presented to CD8+ cytotoxic T cells. Although the crystal structures of several different MHC products have been solved, many MHC molecules, including some associated with diseases, have not been amenable to biochemical and structural studies. The variability in this success is based largely on the fact that peptide-MHC complexes vary extensively in their stability. These properties also are intimately tied to the biological activity of the complexes. The ability to apply the techniques of directed evolution to this system in order to engineer stable complexes has been complicated by the trimeric structure of peptide-MHC complexes, requiring association of three polypeptides: the heavy chain, β2-microglubulin (β2m), and a short peptide. We show here that single-chain forms of peptide-MHC complexes can be expressed as Aga-2 fusions on the surface of yeast. Three different complexes, SIYRYYGL-Kb-β2m (SIYR-Kb), EQYKFYSV-Kb-β2m (dEV8-Kb), and SIINFEKL-Kb-β2m (OVA-Kb), were expressed on yeast and detected by flow cytometry with a conformation-specific anti-Kb antibody (B.8.24.3). In addition, yeast displaying Kb loaded with exogenous SIYR and OVA peptides were recognized by a high-affinity T cell receptor that is specific for SIYR-Kb and by an antibody (25.D1-16) that is specific for OVA-Kb, respectively. Finally, yeast that display the SIYRYYGL-Kb also directly stimulated CD69 up-regulation on naive 2C T cells. Hence, yeast display represents a technology that can be used for directed evolution of any of the components of the trimeric pep-MHC complex.",
keywords = "Agonist peptides, Antigen presentation, Peptide-MHC, T cell activation, Yeast display",
author = "Brophy, {Susan E.} and Holler, {Phillip D.} and Kranz, {David M}",
year = "2003",
month = "1",
day = "15",
doi = "10.1016/S0022-1759(02)00439-8",
language = "English (US)",
volume = "272",
pages = "235--246",
journal = "Journal of Immunological Methods",
issn = "0022-1759",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - A yeast display system for engineering functional peptide-MHC complexes

AU - Brophy, Susan E.

AU - Holler, Phillip D.

AU - Kranz, David M

PY - 2003/1/15

Y1 - 2003/1/15

N2 - In a cellular immune response, antigenic peptides derived by intracellular processing of foreign pathogens are bound to the class I major histocompatability complex (MHC I) and presented to CD8+ cytotoxic T cells. Although the crystal structures of several different MHC products have been solved, many MHC molecules, including some associated with diseases, have not been amenable to biochemical and structural studies. The variability in this success is based largely on the fact that peptide-MHC complexes vary extensively in their stability. These properties also are intimately tied to the biological activity of the complexes. The ability to apply the techniques of directed evolution to this system in order to engineer stable complexes has been complicated by the trimeric structure of peptide-MHC complexes, requiring association of three polypeptides: the heavy chain, β2-microglubulin (β2m), and a short peptide. We show here that single-chain forms of peptide-MHC complexes can be expressed as Aga-2 fusions on the surface of yeast. Three different complexes, SIYRYYGL-Kb-β2m (SIYR-Kb), EQYKFYSV-Kb-β2m (dEV8-Kb), and SIINFEKL-Kb-β2m (OVA-Kb), were expressed on yeast and detected by flow cytometry with a conformation-specific anti-Kb antibody (B.8.24.3). In addition, yeast displaying Kb loaded with exogenous SIYR and OVA peptides were recognized by a high-affinity T cell receptor that is specific for SIYR-Kb and by an antibody (25.D1-16) that is specific for OVA-Kb, respectively. Finally, yeast that display the SIYRYYGL-Kb also directly stimulated CD69 up-regulation on naive 2C T cells. Hence, yeast display represents a technology that can be used for directed evolution of any of the components of the trimeric pep-MHC complex.

AB - In a cellular immune response, antigenic peptides derived by intracellular processing of foreign pathogens are bound to the class I major histocompatability complex (MHC I) and presented to CD8+ cytotoxic T cells. Although the crystal structures of several different MHC products have been solved, many MHC molecules, including some associated with diseases, have not been amenable to biochemical and structural studies. The variability in this success is based largely on the fact that peptide-MHC complexes vary extensively in their stability. These properties also are intimately tied to the biological activity of the complexes. The ability to apply the techniques of directed evolution to this system in order to engineer stable complexes has been complicated by the trimeric structure of peptide-MHC complexes, requiring association of three polypeptides: the heavy chain, β2-microglubulin (β2m), and a short peptide. We show here that single-chain forms of peptide-MHC complexes can be expressed as Aga-2 fusions on the surface of yeast. Three different complexes, SIYRYYGL-Kb-β2m (SIYR-Kb), EQYKFYSV-Kb-β2m (dEV8-Kb), and SIINFEKL-Kb-β2m (OVA-Kb), were expressed on yeast and detected by flow cytometry with a conformation-specific anti-Kb antibody (B.8.24.3). In addition, yeast displaying Kb loaded with exogenous SIYR and OVA peptides were recognized by a high-affinity T cell receptor that is specific for SIYR-Kb and by an antibody (25.D1-16) that is specific for OVA-Kb, respectively. Finally, yeast that display the SIYRYYGL-Kb also directly stimulated CD69 up-regulation on naive 2C T cells. Hence, yeast display represents a technology that can be used for directed evolution of any of the components of the trimeric pep-MHC complex.

KW - Agonist peptides

KW - Antigen presentation

KW - Peptide-MHC

KW - T cell activation

KW - Yeast display

UR - http://www.scopus.com/inward/record.url?scp=0037437910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037437910&partnerID=8YFLogxK

U2 - 10.1016/S0022-1759(02)00439-8

DO - 10.1016/S0022-1759(02)00439-8

M3 - Article

C2 - 12505727

AN - SCOPUS:0037437910

VL - 272

SP - 235

EP - 246

JO - Journal of Immunological Methods

JF - Journal of Immunological Methods

SN - 0022-1759

IS - 1-2

ER -